Pancreatic Cancer and Immunotherapy: A Clinical Overview

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with a dismal prognosis. While immunotherapy has been deemed a breakthrough treatment for various subtypes of cancer, its efficacy in PDAC is limited. This review discusses a wide range of immunotherapies, providing a ge...

Descripción completa

Detalles Bibliográficos
Autores principales: Timmer, Florentine E. F., Geboers, Bart, Nieuwenhuizen, Sanne, Dijkstra, Madelon, Schouten, Evelien A. C., Puijk, Robbert S., de Vries, Jan J. J., van den Tol, M. Petrousjka, Bruynzeel, Anna M. E., Streppel, Mirte M., Wilmink, Johanna W., van der Vliet, Hans J., Meijerink, Martijn R., Scheffer, Hester J., de Gruijl, Tanja D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393975/
https://www.ncbi.nlm.nih.gov/pubmed/34439292
http://dx.doi.org/10.3390/cancers13164138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393975/
https://www.ncbi.nlm.nih.gov/pubmed/34439292
http://dx.doi.org/10.3390/cancers13164138

Ejemplares similares